JPMorgan Chase & Co’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,361
| Closed | -$3.09K | – | 6775 |
|
|
2023
Q2 | $3.09K | Sell |
10,361
-58,769
| -85% | -$17.5K | ﹤0.01% | 5369 |
|
|
2023
Q1 | $30K | Buy |
69,130
+18,180
| +36% | +$7.89K | ﹤0.01% | 5050 |
|
|
2022
Q4 | $59K | Sell |
50,950
-15,300
| -23% | -$17.7K | ﹤0.01% | 4686 |
|
|
2022
Q3 | $154K | Buy |
66,250
+35,774
| +117% | +$83.2K | ﹤0.01% | 4275 |
|
|
2022
Q2 | $68K | Buy |
30,476
+28,670
| +1,587% | +$64K | ﹤0.01% | 4766 |
|
|
2022
Q1 | $17K | Buy |
+1,806
| New | +$17K | ﹤0.01% | 5299 |
|
|
2021
Q4 | – | Sell |
-8,988
| Closed | -$89K | – | 6033 |
|
|
2021
Q3 | $89K | Buy |
+8,988
| New | +$89K | ﹤0.01% | 4774 |
|